FDA Proposes Ban on Hair Relaxers Containing Formaldehyde
The U.S. Food and Drug Administration (FDA) is taking a significant step towards the potential prohibition of formaldehyde and formaldehyde-releasing chemicals in hair smoothing and hair straightening products. This proposed ban aligns with regulations already in place in the European Union and Canada.

Formaldehyde, which is currently regulated and limited to 0.01% in Canada for use in hair straightening products, has raised concerns due to the inhalation of formaldehyde vapors when these products are heated, such as by a hairdryer or flat iron. This vapor exposure is believed to contribute to respiratory problems and an increased risk of specific cancers.
"The use of hair smoothing products containing formaldehyde and formaldehyde-releasing chemicals is associated with short-term adverse health effects, including sensitization reactions and respiratory issues, as well as long-term health risks, such as an elevated likelihood of certain cancers," stated the FDA in its proposed rule.
Research conducted by the U.S. National Institute of Health (NIH) last year revealed a potential link between the use of hair straightening products and a heightened risk of uterine cancer, with a potentially greater impact on Black women due to their higher usage of such products.
It is essential to note that this proposed ban represents the initial phase of the regulatory process. The FDA is now accepting public comments on the proposal. Following a comprehensive review of these comments, the agency will determine whether further action is necessary.
The FDA currently advises against the use of hair-straightening products that contain formaldehyde and similar substances. Formaldehyde gas inhalation can result in a range of adverse effects, from immediate symptoms such as eye and throat irritation, coughing, wheezing, and chest pain, to more chronic issues like frequent headaches, asthma, skin irritation, allergic reactions, and potentially cancer, as stated in a fact sheet available on the agency's website.
2026-10-03
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
First New UV Filter in Nearly 27 Years: BASF's Tinosorb® S Approved by FDA, Marking a Historic Shift for the U.S. Sunscreen Market
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
The role of lauryl-dimethyl-amine-oxide for hair in shampoo
-
FDA delays proposal to ban formaldehyde in hair straighteners
-
Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?
-
Hair Care Products & Heat Styling May Change Indoor Air Composition & Increase VOCs
-
FDA Releases New Resources for Food Traceability Final Rule Compliance
-
Provital's Marine-derived Densinaria Boosts Hair Volume & Strength
-
MANE Unveils FRESHPLEX™: A Multifaceted Hair Experience Defying Discomfort
Recommend Reading
-
FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants
-
关于进一步规范化学品信息发布、加强全球管制目录宣导的公告 Announcement on Further Standardizing the Release of Chemical Information and Strengthening Public Awareness of Global Control Lists
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
Supply and Demand Dynamics Coupled with Cost Fluctuations Lead to February's Volatile Decline in Butadiene Prices in China
-
Supply and Demand Under Pressure: Toluene Market Downward Trend in June
-
February Maleic Anhydride Prices Generally Increased in China
-
Off-season and Cost Decline Lead to a Sharp Drop in DOP Prices in June in China
-
Fundamentals Weakened, Polyester Staple Fiber Price Center of Gravity Shifts Lower